July 5, 2022 Cell Analysis Tools M&A, Partnerships

Bio-Techne Announces Completion of Namocell Acquisition

JULY 05, 2022 MINNEAPOLIS, July 5, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc. The Namocell acquisition adds easy-to-use single cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. Namocell’s instruments and consumables are critical technologies in various workflows in... Read more

June 22, 2022 Cell Analysis Tools Life Science Tools M&A, Partnerships

Bio-Techne to acquire single-cell sorting platform provider Namocel

JUNE 22, 2022 MINNEAPOLIS and MOUNTAIN VIEW, Mo., June 22, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its... Read more